Метастатическое поражение позвоночника у больных раком молочной железы. Факторы прогноза

Метастатическое поражение позвоночника у больных раком молочной железы. Факторы прогноза

Автор: Алиев Мамед Джавадович, Степанова А.М., Мусаев Эльмар Расимович, Валиев Аслан Камраддинович, Гуторов Сергей Львович

Журнал: Сибирский онкологический журнал @siboncoj

Рубрика: Обзоры

Статья в выпуске: 3 (69), 2015 года.

Бесплатный доступ

В обзоре литературы представлены современные данные по факторам, влияющим на продолжительность жизни и онкологический прогноз при диссеминированном раке молочной железы с метастазами в позвоночник.

Рак молочной железы, метастазы в кости, позвоночник, факторы прогноза

Короткий адрес: https://sciup.org/14056545

IDR: 14056545

Список литературы Метастатическое поражение позвоночника у больных раком молочной железы. Факторы прогноза

  • American Cancer Society. Cancer Facts & Figures 2012.http://www. cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf. Accessed April 1, 2013)
  • Mazeron J.J., Lang P., Simon J.M., Toubiana T., Feuvret L., Boisserie G. New devices in radiation oncology//Bull. Cancer. 2009. Vol. 94 (1). P. 109-113
  • Coleman R.E. Clinical features of metastatic bone disease and risk of skeletal morbidity//Clin. Cancer. Res. 2006. Vol. 12 (20 Pt 2). 6243s-6249s
  • Li B.T., Wong M.H., Pavlakis N. Treatment and Prevention of Bone Metastases from Breast Cancer:AComprehensive Review of Evidence for Clinical Practice//J. Clin. Med. 2014. Vol. 3 (1). P. 1-24. doi:10.3390/jcm3010001
  • Chow E., Finkelstein J.A., Sahgal A., Coleman R.E. Metastatic cancer to the bone/In: V.T. DeVita, T.S. Lawrence, S.A. Rosenberg, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011. P. 2192-2204
  • Laufer I., Sciubba D.M., Madera M., Bydon A., Witham T.J., Gokaslan Z.L., Wolinsky J.P. Surgical management of metastatic spinal tumors//Cancer Control. 2012. Vol. 19 (2). P. 122-128
  • Qu Q., Zong Y., Fei X.C., Chen X.S., Xu C., Lou G.Y., Shen K.W. The importance of biopsy in clinically diagnosed metastatic lesions in patients with breast cancer//World J. Surg. Oncol. 2014. Vol. 12. P. 93 DOI: 10.1186/1477-7819-12-93
  • Kuchuka B., Huttonb P., Morettoa T., Ngc C., Addisond L., Clemonsa M. Incidence, consequences and treatment of bone metastases in breast cancer patients -Experience from a single cancer centre//J. Bone Oncol. 2013. Vol. 2 (4). P. 137-144
  • Каллистов В.Е., Николаев А.П., Одинцов С.В., Матякин Г.Г., Чуприк-Малиновская Т.П., Виноградова Н.Н. Основные подходы и результаты консервативного лечения больных с метастазами в кости//IX Российский онкологический конгресс. М., 2005
  • Nishimura R., Arima N. Is triple negative a prognostic factor in Breast Cancer?//Breast Cancer. 2008. Vol. 29 (4). P. 303-308. doi: 10.1007/s12282-008-0042-3
  • Ulmar B., Richter M., Cakir B., Brunner A., Puhl W., Huch K. Surgical treatment and prognosis factors in spinal metastases of breast cancer//Z. Orthop. Ihre Grenzgeb. 2005. Vol. 143 (2). P. 186-194
  • Ripamonti C., Trippa F., Barone G., Maranzano E. Prevention and Treatment of Bone Metastases in Breast Cancer//J. Clin. Med. 2013. Vol. 2. P. 151-175 DOI: 10.3390/jcm2030151
  • Shehadi J.A., Sciubba D.M., Suk I., Suki D., Maldaun M.V., McCutcheon I.E., Nader R., Theriault R., Rhines L.D., Gokaslan Z.L. Surgical treatment strategies and outcome in patients with breast cancer metastatic to the spine: a review of 87 patients//Eur. Spine J. 2007. Vol. 16 (8). P. 1179-1192
  • Berry D.A., Cirrincione C., Henderson I.C., Citron M.L., Bud-man D.R., Goldstein L.J., Martino S., Perez E.A., Muss H.B., Norton L., Hudis C., Winer E.P. Estrogenreceptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer//JAMA. 2009. Vol. 295 (14). P. 1658-1667
  • Jemal A., Siegel R., Ward E. et al. Cancer statistics//CA Cancer J. Clin. 2011. Vol. 57. P. 43-66
  • Lin N.U., Thomssen C., Cardoso F., Cameron D., Cufer T., Fallowfield L., Francis P.A., Kyriakides S., Pagani O., Senkus E., Costa A., Winer E.P. International guidelines for management of metastatic Breast cancer (MBC) from the European School of Oncology (ESO) -MBC Task Force: Surveillance, Staging, and Evaluation of Patients with Early Stage and Metastatic Breast Cancer//Breast 2013. Vol. 22 (3). P. 203-210 DOI: 10.1016/j.breast.2013.03.006
  • Hims I.K., Ditsch N., Lenhard M.S. et al. Prognostic impact of local therapy of the primary tumor in metastatic breast cancer//ASCO Ann Meet, June 1-5, Chicago: Gen Poster Sess. J. Clin. Oncol. 2012. Vol. 30 (Suppl.) Abstr. 1114
  • Reips U.D., Funke F. Interval-level measurement with visual analogue scales in Internet-based research: VAS Generator//Behav. Res. Methods. 2008. Vol. 40 (3). P. 699-704
  • Ahn S.G., Lee H.M., Cho S.H., Lee S.A., Hwang S.H., Jeong J., Lee H.D. Prognostic factors for patients with bone-only metastasis in breast cancer//Yonsei Med. J. 2013. Vol. 54 (5). P. 1168-1177 DOI: 10.3349/ymj.2013.54.5.1168
  • Witham T.F., Khavkin Y.A., Gallia G.L., Wolinsky J.P., Gokaslan Z.L. Surgery insight: current management of epidural spinal cord compression from metastatic spine disease//Nat. Clin. Pract. Neurol. 2006. Vol. 2 (2). P. 87-94
  • Bentzon N., Düring M., Rasmussen B.B., Mouridsen H., Kroman N. Prognostic effect of estrogen receptor status across age in primary breast cancer//Int. J. Cancer. 2010. Vol. 122 (5). P. 1089-1094
  • Sun J.M., Han W., Kim D.W. et al. Clinical relevance of Her-2 expression in node-negative breast cancer patients//Proc. ASCO. 2010. Vol. 23. Abstr. 598
  • Penault-Lorca F., Cayre A., Bouchet Mishellany F., Amat S., Feillel V., Le Bouedec G., Ferrière J.P., De Latour M., Chollet P. Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome//Int. J. Oncol. 2006. Vol. 22 (6). P. 1319-1325
  • Loehberg C.R., Almstedt K., Jud S.M., Haeberle L., Fasching P.A., Hack C.C., Lux M.P., Thiel F.C., Schrauder M.G., Brunner M., Bayer C.M., Hein A., Heusinger K., Heimrich J., Bani M.R., Renner S.P., Hartmann A., Beckmann M.W., Wachter D.L. Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis//Breast Cancer Res. Treat. 2013. Vol. 138 (3). P. 899-908. doi: 10.1007/s10549-013-2460-y
  • DeVita V.T. Jr., Chu E. Ahistory of cancer chemotherapy//Cancer Res. 2008 Vol. 68 (21). P. 8643-8653
  • Carey L.A., Perou C.M., Livasy C.A., Dressler L.G., Cowan D., Conway K., Karaca G., Troester M.A., Tse C.K., Edmiston S., Deming S.L., Geradts J., Cheang M.C., Nielsen T.O., Moorman P.G., Earp H.S., Millikan R.C. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study//JAMA. 2006. Vol. 295 (21). P. 2492-2502
  • Parker J.S., Mullins M., Cheang M.C., Leung S., Voduc D., Vickery T., Davies S., Fauron C., He X., Hu Z., Quackenbush J.F., Stijleman I.J., Palazzo J., Marron J.S., Nobel A.B.,Mardis E., Nielsen T.O., Ellis M.J., Perou C.M., Bernard P.S. Supervised risk predictor of breast cancer based on intrinsic subtypes//J. Clin. Oncol. 2009. Vol. 27 (8). P. 1160-1167 DOI: 10.1200/JCO.2008.18.1370
  • Cheang M.C., Chia S.K., Voduc D., Gao D., Leung S., Snider J., Watson M., Davies S., Bernard P.S., Parker J.S., Perou C.M., Ellis M.J., Nielsen T.O. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer//J. Natl. Cancer. Inst. 2009. Vol. 101 (10). P. 736-750 DOI: 10.1093/jnci/djp082
  • Dent R., Hanna W.M., Trudeau M., Rawlinson E., Sun P., Narod S.A. Pattern of metastatic spread in triple-negative breast cancer//Breast Cancer Res. Treat. 2009. Vol. 115 (2). P. 423-428. doi: 10.1007/s10549-008-0086-2
  • Cheang M.C., Voduc D., Bajdik C., Leung S., McKinney S., Chia S.K., Perou C.M., Nielsen T.O. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype//Clin. Cancer Res. 2009. Vol. 1 (5). P. 1368-1376 DOI: 10.1158/10780432.CCR-07-1658
  • Basu S., Chen W., Tchou J., Mavi A., Cermik T., Czerniecki B., Schnall M., Alavi A. Comparison of triple-negative and estrogen receptorpositive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization//Cancer. 2009. Vol. 112 (5). P. 995-1000
  • Li C.I., Daling J.R., Porter P.L., Porter P.L., Tang M.T., Malone K.E. Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer//J. Clin. On-col. 2009. Vol. 27 (32). P. 5312-5318 DOI: 10.1200/JCO.2009.23.1597
  • Yuan Z.Y., Wang S.S., Gao Y., Su Z.Y., Luo W.B., Guan Z.Z. Clinical Characteristics and Prognosis of Triple-negative Breast Cancer: A Report of 305 Cases//Ai Zheng. 2008. Vol. 27 (6). P. 561-565
  • Gerson R., Alban F., Villalobos A., Serrano A. Recurrence and survival rates among early breast cancer cases with triple negative immunophenotype//Gac. Med. Mex. 2008. Vol. 144 (1). P. 27-34
  • Beslija S., Bonneterre J., Burstein H.J., Cocquyt V., Gnant M., Heinemann V., Jassem J., Köstler W.J., Krainer M., Menard S., Petit T., Petruzelka L., Possinger K., Schmid P., Stadtmauer E., Stockler M., Van Belle S., Vogel C., Wilcken N., Wiltschke C., Zielinski C.C., Zwierzina H. Third consensus on medical treatment of metastatic breast cancer//Ann. Oncol. 2009. Vol. 20 (11). P. 1771-1785 DOI: 10.1093/annonc/mdp261
  • Tokuhashi Y., Matsuzaki H., Oda H., Oshima M., Ryu J. A revised scoring system for preoperative evaluation of metastatic Spine tumor prognosis//Spine. 2005. Vol. 30 (19). P. 2186-2191
  • Tomita K., Kawahara N., Kobayashi T., Yoshida A., Murakami H., Akamaru T. Surgical strategy for spinal metastases//Spine. 2001. Vol. 26 (3). P. 298-306
  • Leithner A., Radl R., Gruber G., Hochegger M., Leithner K., Welkerling H., Rehak P., Windhager R. Predictive value of seven preoperative prognostic scoring systems for spinal metastases//Eur. Spine J. 2008. Vol. 17 (11). P. 1488-1495 DOI: 10.1007/s00586-008-0763-1
  • Валиев А.К., Мусаев Э.Р., Сушенцов Е.А., Алиев М.Д. Хирургическое лечение метастатического поражения костей//Практическая онкология. 2011. Т. 12, № 3. С. 112-116
  • Benjamin U., Richter M., Cakir B., Muche R., Puhl W., Huch K. The Tokuchashi score: significant predictive value for the life expectancy for patients with breast cancer with Spine metastaces//Spine. 2005. Vol. 30 (19). P. 2222-2226
  • Eleraky M., Papanastassiou I., Vrionis F.D. Management of metastatic spine disease//Curr. Opin. Support Palliat. Care. 2011. Vol. 4 (3). P. 182-188. Review DOI: 10.1097/SPC.0b013e32833d2fdd
  • Dean M., Harris J.-D., Regnard C., Hockley J. Emergencies. Symptom Relief in Palliative Care. Oxford, United Kingdom: Radcliffe Publishing; 2011. P. 201-219
  • Waller A., Caroline N.L. Spinal Cord Compression. Handbook of Palliative Care in Cancer. 5nd ed. Boston, MA; 2013. P. 301-308
  • Rades D., Douglas S., Veninga T., Stalpers L.J., Bajrovic A., Rudat V., Schild S.E. Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression//Strahlenther. Onkol. 2012. Vol. 188 (4). P. 340-345 DOI: 10.1007/s00066-011-0061-4
Еще
Статья обзорная
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp